Security
Type

Security Class
Title

Fee
Calculation
or Carry
Forward
Rule

Amount

Registered (1)

Proposed
Maximum Offering
Price Per
Unit

Maximum
Aggregate
Offering
Price(1)(2)

Fee Rate

Amount of
Registration
Fee

Fees to Be Paid

Equity

Units consisting of:(3)

Rule 457(o)

___

___

$17,250,000

0.0001102

$1,900.95

Fees to Be Paid

Equity

(i) Common Stock, par value $0.001 per share(4)

___

___

___

___

___

___

Fees to Be Paid

Equity

(ii) one Investor Warrant to purchase one share of Common Stock(4)

___

___

___

___

___

___

Fees to Be Paid

Equity

Common Stock issuable upon exercise of the Investor Warrants(3)(5)

Rule 457(o)

___

___

$17,250,000

0.0001102

$1,900.95

Fees to Be Paid

Equity

Underwriter Warrants to purchase Common Stock(6)

Rule 457(g)

___

___

___

Fees to Be Paid

Equity

Common Stock issuable upon exercise of the Underwriter Warrants(3)

Rule 457(g)

___

___

$1,552,500

0.0001102

$171.09

Fees Previously Paid

___

___

___

___

___

___

___

$2,204.00

Carry Forward Securities

___

___

___

___

___

___

___

___

Total Offering Amounts

$36,052,500

$3,972.99

Total Fees Previously Paid

$2,204.00

Total Fee Offsets

$0.00

Net Fee Due

$1,768.99

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional shares of common stock, par value $0.001 per share (the “Common Stock”), of Arch Therapeutics, Inc. (the “Company”), as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions.

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.

Includes any additional shares of Common Stock and/or warrants to purchase shares of Common Stock (the “Investor Warrants”) that may be issued upon exercise of the option granted to the underwriters to cover over-allotments, if any.

No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.

The Investor Warrants are exercisable at a per share price of 100% of the price per Unit in this offering.

We have agreed to issue to Maxim Group LLC (or its designees), the representative of the underwriters, warrants (the “Underwriter Warrants”) to purchase the number of shares equal to nine percent (9%) of the shares sold in this offering, including any additional shares of Common Stock that may be issued upon exercise of the option granted to the underwriters to cover over-allotments, if any. The Underwriter Warrants are exercisable at a price per share equal to 110% of the price per Unit in this offering.